The objective of this study was to determine the prevalence of olfactory impairment and associated risk factors and the effects of olfactory impairment on dietary choices and quality of life. Odor identification was measured in 2838 participants aged 21-84 years (mean 49 years) in the Beaver Dam Offspring Study. The overall prevalence of olfactory impairment was 3.8%, increased with age (from 0.6% in those <35 years to 13.9% among those ‡65 years) and was more common in men than women. In a multivariate model age (odds ratio [OR] = 1.48, 95% confidence interval [CI] = 1.33, 1.64 for every 5-year increase), nasal polyps or deviated septum (OR = 2.69, 95% CI = 1.62, 4.48), ankle-brachial index < 0.9 (OR = 3.62, 95% CI = 1.45, 9.01), and smoking (women only) (OR = 2.43, 95% CI = 1.19, 4.98 ever smoked vs. never) were associated with an increased odds of olfactory impairment, whereas higher household income, ‡$50 000 versus <$50 000 per year, was associated with a decreased odds of olfactory impairment (OR = 0.48, 95% CI = 0.31, 0.73). Participants with olfactory impairment were less likely to report that food tasted as good as it used to, or that they experienced food flavors the same. There was no association between olfactory impairment and general health-related quality of life, depressive symptoms, or dietary choices. The prevalence of olfactory impairment was low in this largely middle-aged cohort, and some factors associated with olfactory impairment are potentially modifiable.
Introduction
The sense of smell is responsible for a number of functions including identification and enjoyment of the flavor of foods and odors as well as recognition of hazards in the environment, such as toxins, smoke, and spoiled food. Impairment of olfactory ability therefore has the potential to diminish enjoyment of food and quality of life, affect food choices and may increase the risk for exposure to environmental hazards (Santos et al. 2004) . This is of concern because, in the few population-based studies, olfactory impairment has been found to be common, especially in older adults. In a population-based study of adults 53 years and older (n = 2491), the prevalence of olfactory impairment was 25% (Murphy et al. 2002) . In studies that included younger adults, the prevalence has been only slightly lower; a study in Sweden of adults 20 years of age (n = 1387) and older found a prevalence of 19% with olfactory dysfunction (Bramerson et al. 2004) , whereas a study in Germany (n = 1312) found a prevalence of either hyposmia or anosmia to be 22% (Vennemann et al. 2008) .
Olfactory testing was done as a part of the Beaver Dam Offspring Study (BOSS), a study of familial and birth cohort effects on the aging senses in adults aged 21-84 years. The purpose of this paper is to report the prevalence of olfactory impairment across the adult age spectrum in the general population, ascertain associated risk factors for impairment, and determine the association of olfactory impairment with food enjoyment, dietary choices, and quality of life.
Materials and methods
The BOSS is a study of age-related sensory disorders in the adult children (aged 21-84 years) of participants in the Epidemiology of Hearing Loss Study (EHLS), an ongoing (1993 to present) population-based longitudinal study of hearing, olfaction, cognition, and aging (Cruickshanks et al. 1998) . The details of the EHLS and BOSS have been previously reported (Cruickshanks et al. 1998 (Cruickshanks et al. , 2003 Zhan et al. 2010) . The baseline BOSS examination (n = 3285; 2005-2008) included measures of hearing, vision, olfaction, taste, cognition and cardiovascular health, ocular images of the retina and lens, and an extensive questionnaire. Study examiners were trained and certified in the data collection for all protocols. Written informed consent was obtained from participants prior to examination, and the study was approved by the Health Sciences Internal Review Board at the University of Wisconsin.
The San Diego Odor Identification Test (SDOIT) was used to measure olfaction. The SDOIT is a standardized test with good reliability (test-retest agreement of 96% for classifying olfactory impairment; concordance correlation coefficient of 0.85 [95% confidence interval, CI = 0.79, 0.91] for score), has been shown to be comparable to the Brief Smell Identification Test (B-SIT) for classifying olfactory impairment (Krantz et al. 2009 ), and has been used previously in a large epidemiological study (Murphy et al. 2002; Schubert et al. 2009 ). The specific SDOIT methods have been previously reported (Murphy et al. 2002; Krantz et al. 2009; Schubert et al. 2009; Raynor et al. 2010) . The SDOIT consists of 8 common odorants. A picture array with illustrations of all the odorants plus 12 distracters is available to aid in identification. Prior to the test, participants are asked to identify the pictures in the array. Odorants are presented in a random order and in a manner that prevents visual cues, with a 45 s lag between presentations to minimize adaptation. Participants may say the name of the odorant or point to the picture representing the odorant. If an odor is not identified, the participant is given the correct name of the odorant, and it is presented later in the test sequence to allow for learning of unfamiliar odors. The SDOIT score is the number of odors correctly identified after 2 trials. Olfactory impairment was defined as identifying fewer than 6 of the 8 odorants correctly (Murphy et al. 2002; Schubert et al. 2009 ). This definition of olfactory impairment is the same as was used in the EHLS where 95% of the youngest age group (age 53-59 years) with no report of recent sinus problems scored 6 or higher on the SDOIT (Murphy et al. 2002) . A score less than 6 also corresponds to roughly 2 standard deviations (SDs) below the mean score among the younger participants (21-44 years) in the current study.
Quality of life was assessed using the Medical Outcomes Study Short Form Health Survey (SF-36) (Ware et al. 1993 (Ware et al. , 1994 , which was administered by trained interviewers. These 36 questions ascertain function, well-being, disability, and personal evaluation for both physical and mental health. The questions are grouped into 8 domains and 2 summary scores, the Mental Component Scale (MCS) and the Physical Component Scale (PCS) that consolidate the various aspects of quality of life. The scores range from 0 to 100 with higher scores indicating better quality of life. Participants selfcompleted the Center for Epidemiological Studies Depression Scale (CES-D) for depressive symptoms (Radloff 1977) . The CES-D consists of 20 items, which measure depressive symptoms. Participants were asked to indicate how often they experienced each symptom in the last week on a 4-point scale (0-3). Higher total scores are indicative of more depressive symptoms, and a score greater than 15 is suggestive of mild to moderate depressive symptoms (Radloff 1977) .
Two questions were used to assess the impact of olfactory impairment on the enjoyment of food: ''Do foods you eat now taste as good as when you were younger?'' and ''Do you experience food flavors (e.g., chocolate, vanilla) the same as you used to?.'' Dietary choices were assessed by 4 questions, ''About how many servings of vegetables do you eat (aside from salad and potatoes)?,'' ''About how many servings of fruit do you eat (aside from juices)?,'' ''How often do you add salt to foods?,'' and ''How often do you add sugar or sugar substitutes to foods or beverages?.'' For all 4 questions, participants were able to choose from a wide range of responses from ''Never'' and ''less than once a week'' up to ''4 or more (times) per day.'' For these analyses, the items were collapsed into 2 categories of ''<1 serving per day'' and ''1 or more servings per day'' for vegetable and fruit intake and ''less than once per day'' and ''one or more times per day'' for adding sugar and salt to foods.
Other measures obtained relevant to the current research included height, weight, seated blood pressure (Dinamap Procare 120, GE Medical Systems), carotid artery ultrasound (Biosound AU4, Esaote North America, Inc.), and supine blood pressures in the brachial, posterior tibial, and dorsalis pedis arteries on the right side obtained with a mercury sphygmomanometer (Diagnostix 972, American Diagnostic Corporation) and Doppler (5.0 MHz, Nicolet Elite, CareFusion Corporation). Height and weight were used to calculate the body mass index (BMI) (weight in kg divided by the height in meters squared), and obesity was defined as a BMI greater than or equal to 30 kg/m 2 . Hypertension was defined as a measured systolic blood pressure greater than or equal to 140 mm Hg, a diastolic blood pressure greater than or equal to 90 mm Hg or self-reported physician diagnosed hypertension and taking hypertension medication. The intima plus media thickness (IMT) of the carotid artery was the mean of the wall thickness measurements obtained on the right and left sides in the distal common and proximal internal carotid arteries and bifurcation. The ankle-brachial index (ABI) was calculated using the greater of the 2 systolic ankle pressures obtained divided by the systolic brachial pressure, and an ABI < 0.9 was considered abnormal.
Comprehensive information on demographic factors (age, sex, highest level of education achieved, total household income, occupation, and military service), lifestyle and behavioral factors, olfaction-and taste-related health history, general medical history, and environmental exposures were obtained by questionnaire. Occupation was classified as high risk if the longest held job was in production, farming, or forestry or as a craftsman, operator, fabricator, laborer, or fisherman. A participant was considered to have a nasal condition if they reported ever having nasal polyps or a deviated septum. Nasal congestion was defined as an upper respiratory infection or sinus problems in the last week or a stuffy nose the day of the examination. Participants selfreported if they had a history of allergies (mold, dust, pollen, animals, or foods) or head injury (concussion, broken nose, skull fracture, or loss of consciousness due to a head injury). Medical history included self-reported physician diagnosed history of cardiovascular disease (myocardial infarction, stroke, or angina), epilepsy, Parkinson's disease, Alzheimer's disease, Sjogren's syndrome, any cancer or treatment for cancer (chemotherapy or head or neck radiation), and medication use (statins, nonsteroidal anti-inflammatory medications, or oral steroids). Diabetes was self-reported physician diagnosed or a hemoglobin A1C of 6.5% or greater.
Environmental, lifestyle, and behavioral factors included smoking history (ever smoked 100 cigarettes or more), exposure to environmental tobacco smoke at home, work, and in social situations (Nondahl et al. 2005) , current home environment exposures to heating fuel (gas/electric vs. oil or wood) and cooking fuels (gas vs. electric), physical activity (exercise at least once a week enough to work up a sweat), and a history of heavy alcohol use (4 or more drinks per day).
Statistical analyses
Statistical analyses were conducted using SAS (SAS Systems Inc.). The prevalence of olfactory impairment in the population was assessed, and 95% CIs were calculated using normal approximation where appropriate or the exact binomial method. Potential risk factors for the prevalence of olfactory impairment were tested in age-and sex-adjusted logistic regression models with olfactory impairment as the dependent variable. All variables significant at the 0.20 level were then added to a multivariate model, and a backward elimination procedure was used to successively remove variables that were not significant at the 0.05 level nor were confounders. Interactions with gender were explored. The final model was repeated using a generalized estimating equation to adjust for familial correlations. Factors previously associated with olfactory impairment but with too few cases in this cohort to support analyses included Sjogren's syndrome, Parkinson's disease, Alzheimer's disease, epilepsy, chemotherapy, or head and neck radiation. A sensitivity analysis was run on the final model removing participants with these conditions from the model.
Analysis of covariance models were used to assess the relationship between olfactory impairment and mean SF-36 and CES-D scores with olfactory impairment as the predictor and the SF-36 and CES-D scores as the dependent variables. These analyses were repeated using the olfactory score categories of 0-2, 3-5, and 6-8. Contingency tables and the chisquare test for general association were used to initially assess the relationship between olfactory impairment and dietary choices and food enjoyment. These associations were then evaluated in age-and sex-adjusted logistic regression models.
Results
There were 2838 participants, 1293 (45.6%) men and 1545 (54.4%) women who completed the SDOIT. Of the 447 BOSS participants without an SDOIT, 439 had participated in the interview only. Participants were aged 21-84 years with a mean age of 49 years and 87.7% of the cohort was 35-64 years of age. The overall prevalence of olfactory impairment was 3.8%, increased with age (odds ratio [OR] = 1.55, 95% CI = 1.41, 1.71, for every 5-year increase in age) and was more common in men than women (OR = 2.44, 95% CI = 1.61, 3.68, respectively) ( Table 1) . Participant characteristics by olfactory impairment and factors associated with olfactory impairment in age-and sex-adjusted models are shown in Table 2 . Household income, nasal conditions, allergies, epilepsy, head injury, ABI, using gas as a cooking fuel, and carotid IMT were all associated with olfactory impairment in age-and sexadjusted models. In a multivariate model, age (OR = 1.48, 95% CI = 1.33, 1.64 for every 5-year increase), presence of nasal conditions (OR = 2.69, 95% CI = 1.62, 4.48), and an ABI < 0.9 (OR = 3.62, 95% CI = 1.45, 9.01) were associated with an increased odds of olfactory impairment, whereas a household income of $50 000 per year or more was associated with a decreased odds of olfactory impairment (OR = 0.48, 95% CI = 0.31, 0.73, ‡50 vs. <50 k). There was a significant interaction between sex and smoking in the multivariate model, and a history of smoking was associated with an increased odds of olfactory impairment in women only (OR = 2.43, 95% CI = 1.19, 4.98 for ever smoked vs. never in women; OR = 0.64, 95% CI = 038, 1.08 for ever smoked vs. never in men) (Table 3, model 1). A history of head injury, epilepsy, allergies, carotid IMT, and cooking fuel were not significant in the multivariate model. Participants with an abnormal ABI had significantly thicker carotid IMT (IMT = 0.84 mm among those with an ABI < 0.9 vs. IMT = 0.65 mm among those with an ABI ‡ 0.9, P = 0.0005), and the modeling process was repeated excluding ABI. Carotid IMT was significant in the multivariate model (OR = 1.14, 95% CI = 1.01, 1.27, per 0.1 mm increase) when ABI was excluded from the analyses (Table 3 , model 2).
The multivariate model was repeated controlling for familial correlations, and the results were the same. A sensitivity analysis was conducted repeating the final multivariate model after excluding participants with epilepsy, Parkinson's disease, Sjogren's syndrome, Alzheimer's disease, history of chemotherapy or cancer, or head and neck radiation for cancer; the results did not change.
Quality of life and depressive symptoms
No association was found between quality of life as measured by the SF-36 and olfactory impairment. For the summary SF-36 scores, the mean PCS scores were 49.0 and 49.6 (P = 0.47) and the mean MCS scores were 53.4 and 53.9 (P = 0.53) for those with and without olfactory impairment, respectively, in age-and sex-adjusted models. Similar results were obtained for the individual domain scores. Additionally there was no difference in individual domain or summary mean SF-36 scores comparing those who scored 0-2 with those who scored 6-8 or comparing those who scored 3-5 with those who scored 6-8 on the SDOIT. There was no association between olfactory impairment and the report of depressive symptoms. The mean ageand sex-adjusted CES-D scores were 8.5 and 8.4 for those with and without olfactory impairment (P = 0.81), respectively.
Enjoyment of food
A lower percentage of participants with olfactory impairment reported that foods taste as good now as when they were younger as compared with participants without an olfactory impairment (78.5% vs. 88.5%, respectively; P = 0.002). This association remained after adjusting for age, sex, and smoking (OR = 0.50, 95% CI = 0.30, 0.81). Participants with an olfactory impairment were less likely to report they ''experience food flavors the same as they used to'' than participants without olfactory impairment (82.2% vs. 95.9%, respectively; P < 0.0001). This association remained after adjusting for age, sex, and smoking (OR = 0.21, 95% CI = 0.12, 0.37). Overall, olfactory impairment was not associated with the number of servings of vegetables or fruit eaten or the frequency of adding sugar or salt to foods (Table 4) .
Discussions
This study of primarily middle-aged adults found the overall prevalence of olfactory impairment to be low at 3.8%. This is not unexpected in this cohort where the majority of participants were less than 65 years of age. Consistent with other studies, the prevalence of olfactory impairment increased with age, from less than 1% in those under 35 years to 13.9% in those 65 years and older, and was more common in men than women (Murphy et al. 2002; Bramerson et al. 2004; Vennemann et al. 2008 ). The overall prevalence in BOSS is lower than what was reported in the Skovde (19%) and Dortmund Health (22%) studies, which included similar age ranges (Bramerson et al. 2004; Vennemann et al. 2008 ). This could be due to differences in the age and gender distribution of the study populations. While neither the Skovde nor Dortmund study reported prevalence levels stratified by age and sex, the Skovde study included a higher percentage over 70 years of age and more of those over 70 years were men, as compared with the BOSS cohort, consistent with a higher overall prevalence of impairment (Bramerson et al. 2004 ). The mean age of participants in the Dortmund Health Study was slightly higher than in the BOSS (52 vs. 49 years, respectively) (Vennemann et al. 2008) .
In addition, differences in the methods used to ascertain olfactory dysfunction and severity of dysfunction detected may contribute to the prevalence differences across studies. The Skovde study considered hyposmia to be present if 12 or fewer odors on the 16-item Scandanavian Odor Identification test were correctly identified and the Dortmund study used 10 or fewer on a 12-item Sniffin' Sticks test (Bramerson et al. 2004; Vennemann et al. 2008) . The prevalence of anosmia (<9 in Skovde study and £6 in the Dortmund study) was 5.8% and 3.8%, respectively, which are similar to the current study suggesting that differences in the severity of dysfunction detected may contribute to the higher overall rates in these studies (Bramerson et al. 2004; Vennemann et al. 2008) . Olfactory impairment as measured and defined in the current study may not be detecting mild dysfunction as the prevalence in this study was also similar to the occurrence of moderate-to-severe hyposmia on the University of Pennsylvania Smell Identification Test and severe olfactory problems on the Sniffin' Sticks test (Doty 1995; Hummel et al. 2001) . The EHLS, which also used the SDOIT, found a much higher overall prevalence of olfactory impairment (25%) than the BOSS but that study population was much older (age 53-97 years, mean age 69 years). However, in the youngest EHLS age group, 53-59 years, the prevalence was 6.1% as compared with 7.5% in the current study (55-64 years). Both the current study and the EHLS found the prevalence of olfactory impairment was higher in older age groups and increases substantially at approximately age 55-60 years for men and age 65-70 years for women. Although the patterns of increasing prevalence were similar between the studies, the prevalence levels were lower in the BOSS suggesting the prevalence of olfactory impairment may be decreasing in older adults (Murphy et al. 2002; Schubert et al. 2009 ).
In this study, some of the factors associated with olfactory impairment (age, sex, nasal conditions, smoking, and income) have been reported previously (Frye et al. 1990; Murphy et al. 2002; Silveira-Moriyama et al. 2010; Schubert et al. 2011 ) and some have not (ABI and IMT). Several of these associated risk factors may be modifiable. The association between ABI and olfactory impairment, independent of age and smoking, suggests that cardiovascular health may be important for olfactory health. An abnormal ABI is indicative of peripheral arterial disease (Newman et al. 1993 ) and those with this condition likely have atherosclerotic changes elsewhere in the body, which could include areas responsible for olfaction. Likewise, when ABI was excluded from the modeling process carotid IMT, a subclinical marker of generalized atherosclerosis, was associated with olfactory impairment. The number of participants in this study with an abnormal ABI was low, and the overall contribution to olfactory impairment is comparatively small. However, these results suggest that there may be a relationship between vascular and olfactory health. Further research is needed to confirm these findings. Although previous reports in the literature on the association between income and olfaction are limited (SilveiraMoriyama et al. 2010) , the finding in the current study of less olfactory impairment among those with higher household income is consistent with higher socioeconomic status being associated with better health. Income levels have been found to be inversely associated with cardiovascular disease and all-cause mortality (Kaplan and Keil 1993) and, with regards to sensory health, the EHLS found a higher prevalence of hearing loss among those with lower income (Cruickshanks et al. 1998) . Those with higher income may have better access to health care, utilize health care at a higher rate, or have healthier lifestyles than those with lower incomes.
Smoking was only significantly associated with olfactory impairment among women in this study. Previous studies have found mixed results between smoking and olfactory impairment but gender differences have not been noted (Frye et al. 1990; Murphy et al. 2002; Bramerson et al. 2004; Vennemann et al. 2008; Schubert et al. 2011 ). Frye et al. (1990 found dose-related effects of smoking on odor identification scores among both current and past smokers though only current smokers had higher odds of olfactory dysfunction when compared with never smokers. Likewise, current smokers scored significantly lower on olfactory function tests than those who had never smoked, and pack-years was negatively correlated with olfactory test scores in a small study in Greece (Katotomichelakis et al. 2007 ). Among population-based studies, the EHLS found an increased odds of olfactory impairment among current smokers (vs. never smoked) (Murphy et al. 2002) as did the Dortmund Health Study (Vennemann et al. 2008 ) but the Skovde study did not (Bramerson et al. 2004) .
Increasing age and male gender were associated with olfactory impairment in this study as they have been in other studies (Doty et al. 1984; Murphy et al. 2002; Bramerson et al. 2004) . Nasal conditions, which included a history of nasal polyps or a deviated septum, were strongly associated with olfactory impairment. These conditions have previously been associated with olfactory impairment in both clinicbased and population-based studies (Doty and Mishra 2001; Bramerson et al. 2004; Schubert et al. 2011 ) and may be amenable to treatment.
People often misinterpret a loss or change in food flavors as a problem with their sense of taste not smell (Deems et al. 1991) . Olfactory impairment can affect retronasal olfaction, which is the pathway for identifying and discriminating many food flavors. This study found participants with olfactory impairment were less likely to report that food tasted as good as when they were younger and flavors were less likely to be the same suggesting olfactory impairment is impacting the taste and enjoyment of food for some people. Although this difference was statistically significant, the number of participants with olfactory impairment who were experiencing these changes was low and the majority of those with impairment did not report a change in the taste of food or flavors. There were no associations between dietary choices and olfactory impairment. These results are consistent with the study by Stinton et al. (2010) that reported altered olfactory function had no influence on taste function. In addition, the decrease in odor identification ability in this study was likely at a subclinical level for many participants who may not have been aware of their impairment. This was noted in the EHLS where the sensitivity of self-reported olfactory impairment was 20% in those who were identified as impaired by the SDOIT (Murphy et al. 2002) . Previous studies that have reported complaints of less enjoyment of food or changes in diet in relation to chemosensory problems have been conducted at smell and taste clinics where people are likely to have more severe impairments (Ferris and Duffy 1989; Mattes et al. 1990 ).
This study did not find an association between olfactory impairment and quality of life or depressive symptoms. Studies on olfactory impairment and quality of life and depression have had mixed results (Bramerson et al. 2007; Fischer et al. 2009; Smeets and Veldhuizen 2009) . Some of these studies have been conducted on patients at smell and taste clinics (Miwa et al. 2001; Temmel et al. 2002; Bramerson et al. 2007) or with known anosmia (Smeets and Veldhuizen 2009) . Patients seeking treatment are likely to have more severe symptomology and impairment that is affecting their quality of life as compared with participants in a general population study. In addition, the association has been more consistent in those studies using instruments that specifically measure quality of life in areas related to olfaction (eating, safety, personal hygiene, etc.) (Miwa et al. 2001; Temmel et al. 2002) than with instruments such as the SF-36 that measures general health and well-being (Bramerson et al. 2007; Fischer et al. 2009; Smeets and Veldhuizen 2009) . Our results are similar to a study of multisensory impairment and quality of life in the EHLS, which found no association between olfactory impairment and SF-36 measures (Fischer et al. 2009 ).
There are a few limitations of this study to be noted. Although this study was done in a general population cohort, it is not population-based but represents the children of a population-based cohort. A food frequency questionnaire, dietary recall, or food diary was not used for the assessment of dietary choices, and this may have limited our ability to detect small differences in diet between those with and without olfactory impairment. The strengths of this study include a large cohort with extensive information available on potential risk factors including demographic, health, and environmental factors and the measurement of olfaction versus self-report. The SDOIT is a standardized odor identification test with good reproducibility and is comparable to another validated short smell test, the B-SIT, for classifying impairment (Krantz et al. 2009 ). The number of odorants in the SDOIT may limit the ability to detect small decrements in odor identification or to distinguish hyposmia from anosmia. In addition, the choice of a cut-point for defining impairment affects prevalence; changing the cut-point by just one in either direction would change the prevalence. However, the definition of olfactory impairment used in this study has been previously validated in a large epidemiological study (Murphy et al. 2002) and was approximately 2 SDs less than the mean among younger adults in this study. The SDOIT with its small number of odorants, short administration time, and good reproducibility is well suited for use in epidemiological studies such as this one or as a screening test in clinical settings (Krantz et al. 2009 ).
Conclusion
In conclusion, the prevalence of olfactory impairment was low in this primarily middle-aged cohort, and many of the factors associated with olfactory impairment are potentially modifiable. Impaired olfaction affected the enjoyment of food for some but was not associated with depression, general health-related quality of life, or dietary choices in this general population cohort.
